NI201000063A - AMINAS UNIDAS A LOS MODULADORES DE LA y-SECRETASA. - Google Patents

AMINAS UNIDAS A LOS MODULADORES DE LA y-SECRETASA.

Info

Publication number
NI201000063A
NI201000063A NI201000063A NI201000063A NI201000063A NI 201000063 A NI201000063 A NI 201000063A NI 201000063 A NI201000063 A NI 201000063A NI 201000063 A NI201000063 A NI 201000063A NI 201000063 A NI201000063 A NI 201000063A
Authority
NI
Nicaragua
Prior art keywords
secretase modulators
amines attached
amines
attached
compounds
Prior art date
Application number
NI201000063A
Other languages
English (en)
Inventor
Yung Ho Chih
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NI201000063A publication Critical patent/NI201000063A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se relaciona a compuestos de la Fórmula I como se muestran abajo , en donde las definiciones de A, R1, R2, R3, R4, R5, R6, R7, y R8 se proporcionan en la especificación. Los compuestos de la Fórmula I son útiles para el tratamiento de enfermedades asociadas a la actividad de la y-secretasa, incluyendo la enfermedad de Alzheimer.
NI201000063A 2007-10-19 2010-04-16 AMINAS UNIDAS A LOS MODULADORES DE LA y-SECRETASA. NI201000063A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98117007P 2007-10-19 2007-10-19

Publications (1)

Publication Number Publication Date
NI201000063A true NI201000063A (es) 2010-09-13

Family

ID=40091367

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201000063A NI201000063A (es) 2007-10-19 2010-04-16 AMINAS UNIDAS A LOS MODULADORES DE LA y-SECRETASA.

Country Status (18)

Country Link
US (1) US7951843B2 (es)
EP (1) EP2212280B1 (es)
JP (1) JP5543353B2 (es)
KR (1) KR20100090265A (es)
CN (1) CN101888990B (es)
AU (1) AU2008312653B2 (es)
BR (1) BRPI0817425A2 (es)
CA (1) CA2702835A1 (es)
CO (1) CO6280529A2 (es)
CR (1) CR11436A (es)
EA (1) EA017907B1 (es)
ES (1) ES2447842T3 (es)
IL (1) IL205044A (es)
MX (1) MX2010004308A (es)
NI (1) NI201000063A (es)
NZ (1) NZ584721A (es)
WO (1) WO2009052079A1 (es)
ZA (1) ZA201003518B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101903335A (zh) * 2007-10-19 2010-12-01 詹森药业有限公司 连接有胺的γ-分泌酶调节剂
MX2010004309A (es) * 2007-10-19 2010-05-03 Janssen Pharmaceutica Nv Moduladores de piperidinil y piperazinil de gamma-secretasa.
EP2215043B1 (en) * 2007-10-19 2013-03-06 Janssen Pharmaceutica, N.V. Carbon linked modulators of y-secretase
US20120129189A1 (en) * 2009-07-17 2012-05-24 Chulan Kwon Methods of Controlling Cell Proliferation
WO2011057214A2 (en) * 2009-11-09 2011-05-12 Neurogenetic Pharmaceuticals, Inc. Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877399A (en) * 1994-01-27 1999-03-02 Johns Hopkins University Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
EP1284729A4 (en) * 2000-04-13 2007-12-19 Mayo Foundation REDUCTION AGENTS OF A (BETA) 42
DE10131899A1 (de) 2001-07-04 2003-02-27 Boehringer Ingelheim Pharma In vitro-Screening-Assay für gamma-Secretase
EP2489659B1 (en) * 2004-06-24 2017-12-13 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
GB0416508D0 (en) * 2004-07-23 2004-08-25 Merck Sharp & Dohme Therapeutic agents
EP1650183A1 (en) 2004-10-21 2006-04-26 Cellzome Ag (Benzyloxy-biphenyl) acetic acids and derivatives thereof and their use in therapy
EP2044044A2 (en) * 2006-06-09 2009-04-08 Icos Corporation Substituted phenyl acetic acids as dp-2 antagonists

Also Published As

Publication number Publication date
BRPI0817425A2 (pt) 2015-06-16
CA2702835A1 (en) 2009-04-23
EP2212280B1 (en) 2013-12-04
CN101888990A (zh) 2010-11-17
US7951843B2 (en) 2011-05-31
IL205044A (en) 2015-02-26
ES2447842T3 (es) 2014-03-13
NZ584721A (en) 2011-11-25
KR20100090265A (ko) 2010-08-13
US20090105345A1 (en) 2009-04-23
JP5543353B2 (ja) 2014-07-09
EA017907B1 (ru) 2013-04-30
WO2009052079A1 (en) 2009-04-23
EA201070494A1 (ru) 2010-12-30
JP2011500699A (ja) 2011-01-06
EP2212280A1 (en) 2010-08-04
AU2008312653B2 (en) 2013-03-07
CR11436A (es) 2011-01-14
AU2008312653A1 (en) 2009-04-23
ZA201003518B (en) 2012-07-25
IL205044A0 (en) 2010-11-30
CO6280529A2 (es) 2011-05-20
CN101888990B (zh) 2014-01-29
MX2010004308A (es) 2010-05-03

Similar Documents

Publication Publication Date Title
UY35012A (es) Alcoxipirazoles como activadores de guanilato ciclasa soluble
PA8627201A1 (es) Compuestos de imidazol para el tratamiento de trastornos neurodegenerativos
ECSP12011622A (es) Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurológicos
ECSP13012611A (es) Derivados de pirazol-aminopirimidina como moduladores de la lrrk2
ECSP10010582A (es) Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer
UY32574A (es) Antagonistas del receptor cxcr3
UY30377A1 (es) Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa
ATE534625T1 (de) Substituierte n-phenyl-bipyrrolidinharnstoffe und deren therapeutische verwendung
ECSP15029822A (es) Derivados de imidazopiridazina como moduladores del receptor gabaa
PE20151892A1 (es) Compuestos tetraciclicos sustituidos con heterociclo y metodos de uso de los mismos para el tratamiento de enfermedades viricas
NI201000063A (es) AMINAS UNIDAS A LOS MODULADORES DE LA y-SECRETASA.
AR081908A1 (es) N-heteroaril-espirolactama-bipirrolidinas sustituidas, preparacion y usos terapeuticos de las mismas
NI201000065A (es) CARBONO UNIDO A LOS MODULADORES DE LA y-SECRETASA.
CR11447A (es) Moduladores de piperidinil y piperazinil de y secretasa
UY32747A (es) 2-carboxamida-cicloamino-ureas sustituidas
UY32002A (es) Piridinilo moduladores de gamma-secretasa
CR9815A (es) Compuestos de imidazol para el tratamiento de transtornos neurologicos
NI201000066A (es) AMINAS UNIDAS A LOS MODULADORES DE LA y-SECRETASA.
NI201000067A (es) Intermediarios de gsm.
CR20120131A (es) Uso de derivados del indol como activadores de nurr-1, para su aplicación como medicamento en el tratamiento de la enfermedad de parkinson
UY30134A1 (es) Derivados de biciclo (2.2.1)hept-7-ilamina
UY27289A1 (es) Derivados de oxazol
DOP2004000966A (es) Compuestos heteroarilo de 6 miembros para el tratamiento de trastornos neurodegenerativos
CU23591B7 (es) Compuestos de imidazol para el tratamiento de desórdenes neurovegetativos